Myc activates telomerase.

Telomere maintenance has been proposed as an essential prerequisite to human tumor development. The telomerase enzyme is itself a marker for tumor cells, but the genetic alterations that activate the enzyme during neoplastic transformation have remained a mystery. Here, we show that Myc induces telomerase in both normal human mammary epithelial cells (HMECs) and normal human diploid fibroblasts. Myc increases expression of hEST2 (hTRT/TP2), the limiting subunit of telomerase, and both Myc and hEST2 can extend the life span of HMECs. The ability of Myc to activate telomerase may contribute to its ability to promote tumor formation.

[1]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[2]  P. McDonough,et al.  Immunocytochemical study of ras and myc proto-oncogene polypeptide expression in the human menstrual cycle. , 1989, American journal of obstetrics and gynecology.

[3]  Bas van Steensel,et al.  Control of telomere length by the human telomeric protein TRF1 , 1997, Nature.

[4]  J. Shay,et al.  E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. , 1993, Oncogene.

[5]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[6]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[7]  T. Tamaya,et al.  Telomerase activity in the human endometrium throughout the menstrual cycle. , 1998, Molecular human reproduction.

[8]  C. Greider.  Telomerase activity, cell proliferation, and cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. McDougall,et al.  Telomerase activation by the E6 gene product of human papillomavirus type 16 , 1996, Nature.

[10]  J. Watson.  Origin of concatemeric T7 DNA. , 1972, Nature: New biology.

[11]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[12]  J. D. Watson.  Origin of Concatemeric T7DNA , 1972 .

[13]  A M Olovnikov,et al.  A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.

[14]  R. Eisenman,et al.  Myc target genes. , 1997, Trends in biochemical sciences.

[15]  M. Bass,et al.  Human telomerase contains evolutionarily conserved catalytic and structural subunits. , 1997, Genes & development.

[16]  E. Blackburn,et al.  Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines , 1996, Molecular and cellular biology.

[17]  G. Stein,et al.  Origins of G1 arrest in senescent human fibroblasts , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[18]  L. Gollahon,et al.  Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome , 1995, Molecular and cellular biology.

[19]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[20]  J. Shay,et al.  Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.

[21]  H. Shirasawa,et al.  Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein. , 1997, Virology.

[22]  J. Lacy,et al.  Induction of c-myc expression in human B lymphocytes by B-cell growth factor and anti-immunoglobulin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Broccoli,et al.  Telomerase activity in normal and malignant hematopoietic cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Harley,et al.  Telomerase activity in human ovarian carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[26]  J. Shay,et al.  Multiple pathways for the regulation of telomerase activity. , 1997, European journal of cancer.

[27]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[28]  R. Reddel,et al.  Telomere dynamics and telomerase activity in in vitro immortalised human cells. , 1997, European journal of cancer.

[29]  G. Birnie,et al.  Temporal relationships between induced changes in c-myc mRNA abundance, proliferation, and differentiation in HL60 cells. , 1992, Differentiation; research in biological diversity.

[30]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[31]  B. Sobel,et al.  Overexpression of plasminogen activator inhibitor type‐1 in senescent fibroblasts from normal subjects and those with Werner syndrome , 1994, Journal of cellular physiology.

[32]  C B Harley,et al.  Telomerase catalytic subunit homologs from fission yeast and human. , 1997, Science.

[33]  June Corwin,et al.  Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .

[34]  D. Gottschling,et al.  TLC1: template RNA component of Saccharomyces cerevisiae telomerase. , 1994, Science.

[35]  Keiko Hiyama,et al.  Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.

[36]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[37]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  K. Alitalo,et al.  myc oncogenes: activation and amplification. , 1987, Biochimica et biophysica acta.

[39]  J. Shay,et al.  Telomerase activity in human cancer. , 1996, Current opinion in oncology.

[40]  U. Siebenlist,et al.  Mitogenic activation of normal T cells leads to increased initiation of transcription in the c-myc locus. , 1988, Journal of Biological Chemistry.

[41]  H. Shirasawa,et al.  Transactivation of Prothymosin α and c-mycPromoters by Human Papillomavirus Type 16 E6 Protein , 1997 .

[42]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[43]  Gregg B. Morin,et al.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT , 1997, Nature Genetics.

[44]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.